Editorial
 NATIONAL IPR POLICY   
 Thursday, September 03, 2015 
 Implementation of India’s amended Patent Act allowing grant of product patent in pharmaceutical industry has been facing major hurdles ever since 2005 with the long drawn litigations in the patent offices and various courts in the country. 
  Past Editorial...  
TODAY'S NEWS
13:00  [IST]NovaBay Pharma, OIC enter agreement to distribute Avenova in New Zealand
12:30  [IST]IIL conducts seminar on ‘impact of climate change on emergence of new diseases’ in Hyderabad
12:00  [IST]AstraZeneca's Brilinta gets US FDA expanded indication approval to include long-term use in patients with history of heart attack
11:00  [IST]Generex formalises buccal cannabis co-development arrangement with CannScience Innovations
10:00  [IST]Roche's investigational medicine ACE910 gets US FDA breakthrough therapy designation for people with haemophilia A with factor VIII inhibitors
09:00  [IST]Allergan to buy glaucoma treatment company AqueSys for $300 million
more news >>
TOP NEWS
08:00  [IST]CDSCO sub-committee for online pharmacy to meet on September 7, slated to deliberate on dedicated norms
08:00  [IST]Stempeutics conducts largest global phase 2 trial in patients with Buerger’s disease
08:00  [IST]Synegne International plans a greenfield project at Mangalore SEZ at a cost of $100 mn
08:00  [IST]Tamil Nadu pharmacy council to go high tech for hassle-free registration and renewal services
08:00  [IST]Centogene ties up with Sir Ganga Ram Hospital to provide molecular genetic testing in India
08:00  [IST]ICMR issues draft consensus document for management of paediatric lymphomas and solid tumours
more news >>
YESTERDAY'S NEWS
18:00  [IST]Novo Nordisk invests DKK 500 mn in new raw material warehouse in Denmark
17:00  [IST]Amgen seeks EU marketing approval for etelcalcetide to treat SHPT in patients with CKD on hemodialysis therapy
16:00  [IST]Allergan gets US FDA nod for updated label for Teflaro to treat patient with ABSSSI & CABP
15:35  [IST]Lupin launches first ever variant of anti-depressent drug, duloxetine in US
15:05  [IST]Apollo Hospitals Chennai leads the way in high risk pregnancy
15:00  [IST]Lannett to buy UCB's specialty generic pharma unit, Kremers Urban Pharma for $1.23 bn
more news >>
INTERVIEW  
IDMA taking steps to strengthen and tap biz opportunities for SMEs
S.V. Veerramani, the new president of the Indian Drugs Manufacturers Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Should the Pharmacy Inspectors be stopped from inspecting pharmacy outlets as is being demanded by All Kerala Chemists and Druggists Association ?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |